New drug shows promise for tough ulcerative colitis cases
NCT ID NCT06626165
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This study tested whether mirikizumab can help people with moderate to severe ulcerative colitis that hasn't responded to standard treatments. 100 adults took part. Researchers looked for improvements in symptoms, colon healing, and tissue health. The goal was to see if mirikizumab could better control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Showa Inan General Hospital
Komagane, Nagano, 399-4117, Japan
Conditions
Explore the condition pages connected to this study.